Hsiao-Yi Lin

536 citations
22 papers · 386 indexed · h-index 12
Topics
Gout, Hyperuricemia, Uric Acid (4 papers)Inflammatory mediators and NSAID effects (3 papers)Case Reports on Hematomas (3 papers)
Partner nations
TaiwanChinaUnited States

In The Last Decade

Hsiao-Yi Lin

20 papers receiving 377 citations

Peers

Hsiao-Yi Lin
Comparison fields: 5 of 75
  • Nephrology 142
  • Rheumatology 116
  • Molecular Biology 94
  • Pathology and Forensic Medicine 82
  • Epidemiology 72
Replace F. Arellano with:
F. Arellano Spain
Shaoxian Hu China
Nagwa Mohamed Egypt
Rosa Weiss Telles Brazil
Han‐Ming Lai Taiwan
Jieyu He China
Hitoshi Kusano Japan
Magaly Alva Peru
Chris Rivard United States
Hiroya Hashimoto Japan
Hsiao-Yi Lin relative to F. Arellano Spain F. Arellano's profile →
Citations per field
00.5×4.1×
F. Arellano · 1×
Citations per year

Countries citing papers authored by Hsiao-Yi Lin

Since Specialization
Citations

This map shows the geographic impact of Hsiao-Yi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsiao-Yi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsiao-Yi Lin more than expected).

Fields of papers citing papers by Hsiao-Yi Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsiao-Yi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsiao-Yi Lin. The network helps show where Hsiao-Yi Lin may publish in the future.

Co-authorship network of co-authors of Hsiao-Yi Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Hsiao-Yi Lin. A scholar is included among the top collaborators of Hsiao-Yi Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsiao-Yi Lin. Hsiao-Yi Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 10
3 3
4 10
5 38
6 43
7 19
8 1
9 13
10 18
11 25
12 31
13 29
14 9
15 0
16 15
17 1
18 23
19
Lesch-Nyhan Syndrome: report on two brothers.
1
20 11

About Hsiao-Yi Lin

Hsiao-Yi Lin is a scholar working on Nephrology, Rheumatology and Clinical Biochemistry, having authored 22 papers that have together received 386 indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (4 papers), Inflammatory mediators and NSAID effects (3 papers) and Case Reports on Hematomas (3 papers). The work is most often cited by research in Nephrology (142 citations), Rheumatology (116 citations) and Pathology and Forensic Medicine (82 citations). Hsiao-Yi Lin has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Pesus Chou, Shih‐Tzer Tsai, Wen‐Ting Yeh, Wen‐Harn Pan, Joung‐Liang Lan, Wen‐Miin Liang, Gregory J. Tsay, Chi‐Fung Cheng, Jiunn‐Horng Chen and Wei‐Sheng Chen. Their work appears in journals such as PLoS ONE, Arthritis Research & Therapy and IEEE Electron Device Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026